Your browser doesn't support javascript.
loading
Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults.
Spencer, Sarah; Chung, Jessie R; Belongia, Edward A; Sundaram, Maria; Meece, Jennifer; Coleman, Laura A; Zimmerman, Richard K; Nowalk, Mary Patricia; Moehling Geffel, Krissy; Ross, Ted; Carter, Chalise E; Shay, David; Levine, Min; Liepkalns, Justine; Kim, Jin Hyang; Sambhara, Suryaprakash; Thompson, Mark G; Flannery, Brendan.
Affiliation
  • Spencer S; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Chung JR; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Belongia EA; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.
  • Sundaram M; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.
  • Meece J; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.
  • Coleman LA; Translational Medicine, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Zimmerman RK; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.
  • Nowalk MP; Schools of Medicine Department of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Moehling Geffel K; Schools of Medicine Department of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Ross T; Schools of Medicine Department of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Carter CE; Center for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.
  • Shay D; Schools of Medicine Department of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Levine M; Center for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.
  • Liepkalns J; Schools of Medicine Department of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Kim JH; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Sambhara S; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Thompson MG; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Flannery B; Department of Biology, University of Washington, Seattle, Washington, USA.
Influenza Other Respir Viruses ; 16(3): 562-567, 2022 05.
Article in En | MEDLINE | ID: mdl-34859584
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Diabetes Mellitus, Type 2 / Influenza, Human Limits: Aged / Aged80 / Humans / Middle aged Language: En Journal: Influenza Other Respir Viruses Journal subject: VIROLOGIA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Diabetes Mellitus, Type 2 / Influenza, Human Limits: Aged / Aged80 / Humans / Middle aged Language: En Journal: Influenza Other Respir Viruses Journal subject: VIROLOGIA Year: 2022 Type: Article Affiliation country: United States